Method for treatment of nocturia
View Patent ↗A method for treatment of nocturia by administering to a mammal, such as a human, in need of such treatment, a therapeutically effective amount of loxoprofen or a pharmacologically acceptable salt thereof.
1. A method for the treatment of nocturia which consists of administering to a mammal in need of such treatment a therapeutically effective amount of a nonsteroidal anti-inflammatory drug consisting of loxoprofen or a pharmacologically acceptable salt thereof.
2. The method according to claim 1 , wherein loxoprofen or a pharmacologically acceptable salt thereof is loxoprofen.
3. The method according to claim 1 , wherein the mammal is a human.
4. The method according to claim 2 , wherein the mammal is a human.
5. The method according to claim 1 , wherein the mammal is a human whose frequency of nocturia at baseline is 3 or more voids/night and the number of voids per night is reduced by 1 or more times in more than 77% of the humans after the treatment, and wherein the administration is once daily.
6. The method according to claim 1 , wherein the mammal is a human whose frequency of nocturia at baseline is 3 to 5 voids/night and the number of voids per night is reduced by 1 or more times in more than 78% of the humans after the treatment, and wherein the administration is once daily.
7. A method for the treatment of nocturia which consists of administering to a mammal in need of such treatment a therapeutically effective amount of a nonsteroidal anti-inflammatory drug consisting of a pharmacologically acceptable sodium salt of loxoprofen.
8. The method according to claim 7 , wherein the mammal is a human.
9. The method according to claim 7 , wherein the mammal is a human whose frequency of nocturia at baseline is 3 or more voids/night and the number of voids per night is reduced by 1 or more times in more than 77% of the humans after the treatment, and wherein the administration is once daily.
10. The method according to claim 7 , wherein the mammal is a human whose frequency of nocturia at baseline is 3 to 5 voids/night and the number of voids per night is reduced by 1 or more times in more than 78% of the humans after the treatment, and wherein the administration is once daily.